Pharmacologic Targets and Peritoneal Membrane Remodeling

Peritoneal dialysis (PD) is associated with functional and structural changes of the peritoneal membrane, also known as peritoneal remodeling. The peritoneal membrane is affected by many endogenous and exogenous factors such as cytokines, PD fluids, and therapeutic interventions. Here, we present an...

Full description

Saved in:
Bibliographic Details
Published in:Peritoneal dialysis international 2014-01, Vol.34 (1), p.114-123
Main Authors: Farhat, Karima, Stavenuiter, Andrea W.D., Beelen, Rob H.J., ter Wee, Piet M.
Format: Article
Language:English
Subjects:
Original
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Peritoneal dialysis (PD) is associated with functional and structural changes of the peritoneal membrane, also known as peritoneal remodeling. The peritoneal membrane is affected by many endogenous and exogenous factors such as cytokines, PD fluids, and therapeutic interventions. Here, we present an overview of various studies that have investigated pharmacologic interventions aimed at regression of peritoneal damage and prolongation of PD treatment.
ISSN:0896-8608
1718-4304
DOI:10.3747/pdi.2011.00332